CHEK2 rs121918505: What Your Genotype Means
The rs121918505 variant is a rare genetic change located within the CHEK2 gene. Research has identified this specific variant as a population-enriched risk factor in Estonian and Finnish cohorts, where it is associated with certain female reproductive health conditions.
What each genotype means
Typical CHEK2 genetic profile
This genotype represents the most common sequence found in the general population for this specific location in the CHEK2 gene. It is considered the baseline or reference state, and there is no evidence suggesting this specific configuration contributes to the reproductive health risks identified in research cohorts.
This is the most common genotype observed across all global populations.
Enriched reproductive risk factor
Carrying one copy of this variant has been identified as a population-enriched risk factor in Estonian and Finnish cohorts, where it is associated with certain female reproductive health conditions. Because this variant is rare in most other European populations, its clinical significance may vary based on your specific ancestry and family health history.
This genotype is rare in general European populations but is found at higher frequencies in specific isolated populations such as those in Finland and Estonia.
Potential reproductive risk factor
Carrying two copies of this variant is associated with the reproductive health conditions identified in specific research cohorts. As this variant is rare outside of specific isolated populations, you should discuss these findings with a genetic counselor or healthcare provider to understand how this may relate to your personal health context.
This genotype is extremely rare and is primarily observed in specific isolated populations where the variant is enriched.
Understanding the Variant and Its Location
The variant rs121918505 is a specific change in the DNA sequence located within the CHEK2 gene. In genomics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is notable because it is not found at high frequencies across the global population. Instead, it has been identified as a population-enriched variant, meaning it appears more frequently in specific geographic groups, particularly those of Estonian and Finnish ancestry. By studying these specific cohorts, researchers can identify rare genetic markers that might otherwise be missed in broader, more diverse population studies. Understanding where this variant sits in the genome is the first step in determining how it might influence biological processes.
The Role of the CHEK2 Gene
The CHEK2 gene provides instructions for making a protein that acts as a critical checkpoint in the cell cycle. This protein is essential for cellular quality control, as it monitors DNA for damage and helps coordinate the necessary repairs. When DNA damage is detected, the CHEK2 protein helps decide whether the cell should pause its division to fix the error or undergo programmed cell death if the damage is too severe to repair. Because of this function, CHEK2 is widely recognized as a tumor suppressor gene. Its role in maintaining genomic stability is vital for overall health, and variations in this gene can potentially alter how cells respond to stress or damage, which is why it is a frequent subject of study in both cancer research and reproductive health.
Research and Reproductive Health Associations
Current research, particularly studies involving the Estonian Biobank and the FinnGen project, has highlighted rs121918505 as a genetic risk factor associated with female reproductive health. Specifically, investigations have looked at how variants in CHEK2 may influence conditions such as polycystic ovary syndrome (PCOS). The evidence for this association is considered moderate, as these conditions are multifactorial, meaning they are influenced by a complex interplay of genetics, environment, and lifestyle factors. While the statistical association between this variant and reproductive health traits has been observed in specific northern European populations, it is important to note that the presence of the variant does not guarantee the development of a condition. Further research is ongoing to fully understand the biological mechanisms by which this specific variant impacts ovarian function and reproductive health.
Population Frequency and Distribution
The frequency of rs121918505 is notably low in the general global population. However, it shows significant enrichment in specific isolated populations, most notably in Finland and Estonia. This pattern of distribution is often the result of historical demographic events, such as founder effects, where a variant becomes more common in a group due to the limited genetic diversity of the population's ancestors. Because this variant is rare outside of these specific northern European groups, its clinical relevance is primarily studied within these contexts. Researchers emphasize that the enrichment of such variants provides a unique opportunity to study the genetic architecture of complex traits that might be difficult to detect in larger, more heterogeneous populations where the variant is diluted.
Interpreting Your Genetic Information
If you have information regarding your status for rs121918505, it is important to view it within the context of your overall health and family history. Genetic variants are only one piece of a much larger puzzle that includes your environment, lifestyle, and other genetic factors. This information should not be used to diagnose any condition or to make medical decisions on your own. If you are concerned about reproductive health or your genetic risk profile, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your personal medical history and provide guidance on whether further clinical screening or specialized testing is necessary for your specific situation.
How common is this variant?
The rs121918505 variant is rare in general European populations but is enriched in specific isolated populations, particularly in Estonia and Finland.
Frequently asked questions
What is the CHEK2 gene?
The CHEK2 gene encodes a protein that acts as a tumor suppressor by monitoring DNA damage and regulating the cell cycle. It is essential for maintaining genomic stability and cellular quality control.
Is rs121918505 a cause of PCOS?
Research has identified a statistical association between this variant and reproductive health conditions like PCOS in specific populations. However, PCOS is a multifactorial condition, and this variant is only one of many potential contributing factors.
Should I be worried if I have this variant?
Having a genetic variant does not mean you will develop a health condition. You should discuss your results with a healthcare professional or genetic counselor who can evaluate your personal and family health history.
Why is this variant common in Finland and Estonia?
The higher frequency of this variant in these regions is likely due to historical demographic factors, such as founder effects, which can cause certain rare variants to become more common in isolated populations.
Sources & further reading
Educational information only, last refreshed 9/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918505?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29